- Nachrichtendetail
-
20.06.2024 14:10:15 - dpa-AFX: *J&J : TREMFYA PHASE 3 CROHN'S DISEASE STUDY ACHIEVES ALL PRIMARY AND SECONDARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 143,760 | 25.07.24 13:27:48 | +1,040 | +0,73% | 143,760 | 144,060 | 144,000 | 142,720 |
